Here are three stocks that currently hold a buy rating and demonstrate strong momentum for investors to consider on January 9:
Three Promising Stocks to Watch: Strong Momentum and Buy Ratings
Gain Therapeutics, Inc. (GANX)
This biotechnology firm boasts a Zacks Rank of #1. Recently, the Zacks Consensus Estimate for its current year earnings has risen by 4.8% in the past 60 days.
Gain Therapeutics, Inc. Price and Consensus
Gain Therapeutics, Inc. price-consensus-chart | Gain Therapeutics, Inc. Quote
Over the last three months, Gain Therapeutics’ shares have surged by 23.9%, far outpacing the S&P 500’s rise of 2.2%. This company holds a Momentum Score of B.
First Hawaiian, Inc. (FHB)
This bank holding company, associated with First Hawaiian Bank, has also achieved a Zacks Rank of #1, with a 0.6% uptick in the Zacks Consensus Estimate for current year earnings over the past 60 days.
First Hawaiian, Inc. Price and Consensus
First Hawaiian, Inc. price-consensus-chart | First Hawaiian, Inc. Quote
First Hawaiian’s stock price increased by 10.5% over the last three months, again outperforming the S&P 500’s growth of 2.2%. This company currently holds a Momentum Score of A.
The Travelers Companies, Inc. (TRV)
This insurance provider is ranked #1 by Zacks, with a 1.6% increase in the Zacks Consensus Estimate for this year’s earnings observed in the last 60 days.
The Travelers Companies, Inc. Price and Consensus
The Travelers Companies, Inc. price-consensus-chart | The Travelers Companies, Inc. Quote
Shares of The Travelers Companies have appreciated by 4.6% in the past three months against the S&P 500’s 2.2% rise. The company’s Momentum Score stands at B.
Further Insights
To explore additional top-ranked stocks, check the full list here.
For details on how the Momentum Score is calculated, click here.
Research Chief Highlights “Best Pick to Double”
After evaluating numerous stocks, five Zacks experts have selected their top choices, each expected to gain +100% or more in the coming months. Among these, Sheraz Mian, Director of Research, identifies one with significant upside potential.
This company appeals to millennial and Gen Z consumers, generating nearly $1 billion in revenue last quarter alone. A recent stock pullback marks a prime entry point. While not all of Zacks’ elite picks succeed, this one shows promise, potentially exceeding earlier successes like Nano-X Imaging, which rose by +129.6% in just nine months.
Free: See Our Top Stock And 4 Runners Up
For the latest recommendations from Zacks Investment Research, download 7 Best Stocks for the Next 30 Days for free.
The Travelers Companies, Inc. (TRV): Free Stock Analysis Report
First Hawaiian, Inc. (FHB): Free Stock Analysis Report
Gain Therapeutics, Inc. (GANX): Free Stock Analysis Report
To read this article on Zacks.com, click here.
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
